The Feasibility and Acceptability of LIFFE: A Web-Based Vaping Intervention and Smoking Prevention Program for Young Adults
Abstract
Objective. E-cigarette use (i.e., vaping) among young adults increases risk for significant health consequences and combustible cigarette uptake. Although there are a growing number of vaping cessation interventions for young adults, there are no known evidence-based e-cigarette use treatments that include smoking uptake prevention. The Live Free From E-Cigarettes (LIFFE) digital program was developed to help young adults stop or reduce their use of e-cigarettes and reduce their cigarette smoking susceptibility. Method. Twenty young adults (ages 18–24) who vape, but do not smoke combustible cigarettes, were recruited via social media. They completed an initial survey and the single session, 30-minute intervention on their mobile devices, followed by quantitative measures of intervention feasibility and acceptability. One week later, participants completed an interview to provide feedback about the program and a follow-up survey. Results. All participants completed all seven intervention modules. Participants rated LIFFE as feasible in terms of delivery, usability, and logistics. Participants were satisfied with the content, design, and potential to help them and other young adults who vape to stop or reduce use. Some participants reported reductions in their susceptibility to smoke and vaping behaviors, including via quitting, one week after the intervention. Conclusions. Quantitative and qualitative results indicate that LIFFE is a feasible and acceptable program for…
Read the paper
Related studies
- Tobacco and COPD: presenting the World Health Organization (WHO) Tobacco Knowledge Summary
- Comparative effects of e-cigarette smoking on periodontal status, salivary pH, and cotinine levels
- Association between exposure to environmental pollutants and increased oral health risks, a comprehensive review
- Influence of gestational window on offspring vascular health in rodents with in utero exposure to electronic cigarettes
- Natural products as kinase inhibitors in lung cancer: molecular mechanisms, therapeutic potential, and clinical trials
- Nicotine in electronic cigarettes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.